Related Experiment Video
Updated: Jun 25, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
A child presenting with acute renal failure secondary to a high dose of indomethacin: a case report
Felipe González1, Jesús López-Herce, Cinta Moraleda
1Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. pielvi@ya.com.
Insights
A medication error led to a 20-day-old infant receiving a massive dose of indomethacin, causing acute renal failure. The infant recovered fully after renal replacement therapy, highlighting the need for improved drug safety systems in pediatric care.
Area of Science:
- Pediatric Nephrology
- Clinical Pharmacology
- Medication Safety
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) at therapeutic doses typically cause mild, transient renal impairment.
- Limited data exists on high-dose indomethacin toxicity in pediatric populations.
- This case highlights a rare instance of severe acute renal failure in an infant due to a medication error.
Purpose of the Study:
- To describe a case of acute renal failure in a child resulting from an excessively high dose of indomethacin.
- To review a medication error within a drug prescription and administration system.
- To emphasize the importance of robust safety protocols in pediatric critical care.
Main Methods:
- A 20-day-old infant, post-surgery for Fallot's tetralogy, received an accidental indomethacin overdose (10 mg/kg).
- The infant developed acute, oligo-anuric renal failure.
- Treatment involved continuous venovenous renal replacement therapy.
Main Results:
- The infant experienced severe acute renal failure requiring intensive intervention.
- Complete recovery of renal function was achieved without any lasting complications.
- The case underscores the potential for severe toxicity from NSAID overdose in neonates.
Conclusions:
- High-dose indomethacin can precipitate severe acute renal failure in infants.
- Supervised drug prescription and administration systems with multi-level controls are crucial for preventing medication errors in critically ill children.
- Enhanced vigilance and system improvements are necessary to ensure patient safety in pediatric pharmacotherapy.
Introduction:
Acute renal failure caused by nonsteroidal anti-inflammatory drugs administered at therapeutic doses is generally mild, non-anuric and transitory. There are no publications on indomethacin toxicity secondary to high doses in children. The aim of this article is to describe acute renal failure secondary to a high dose of indomethacin in a child and to review an error in a supervised drug prescription and administration system.
Case Presentation:
Due to a medication error, a 20-day-old infant in the postoperative period of surgery for Fallot's tetralogy received a dose of 10 mg/kg of indomethacin, 50 to 100 times higher than the therapeutic dose. The child presented with acute, oligo-anuric renal failure requiring treatment with continuous venovenous renal replacement therapy, achieving complete recovery of renal function with no sequelae.
Conclusion:
In order to reduce medication errors in critically ill children, it is necessary to develop a supervised drug prescription and administration system, with controls at various levels.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
